Skip to content
Recruiting Phase 3

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma

About this study

Evaluation of a therapeutic protocol based on the combination of photodynamic therapy and sonodynamic therapy, referred to as sonophotodynamic therapy. Since this new protocol is applied in a single day, it is called the single-visit Sono-PDT protocol. This protocol will be used for the treatment of nodular basal cell carcinoma lesions.

Condition
Nodular Basal Cell Carcinoma of Skin
Tested
Control Arm (Conventional Therapy), Experimental arm
Sponsor
University of Sao Paulo

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 5

  • Minimum age: 18 years
  • Study condition: Nodular Basal Cell Carcinoma of Skin
  • Adults of both sexes, aged 18 years and older.
  • Histologically confirmed nodular basal cell carcinoma with lesion diameter ≤1.0 cm.
  • Participants with multiple lesions may be included, provided that each lesion meets all inclusion criteria.

Exclusion 8

  • Nodular basal cell carcinoma lesions \>1.0 cm in diameter.
  • Known hypersensitivity or allergy to methyl aminolevulinate (MAL) or any excipients of the study medication.
  • Histological subtypes of infiltrative basal cell carcinoma, including micronodular, infiltrative, sclerodermiform (morpheaform), plano-cicatricial, or terebrant subtypes.
  • Porphyria or other disorders of porphyrin metabolism.
  • Pregnant or breastfeeding women.
  • Women of childbearing potential not using an acceptable method of contraception.
  • Presence of photosensitive diseases, including lupus erythematosus.
  • Any condition that, in the investigator's opinion, would interfere with study participation or safety.

Where

1 site, 1 recruiting

Hospital Amaral Carvalho

Jaú, São Paulo, Brazil

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.